ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "RNA"

  • Abstract Number: 0061 • ACR Convergence 2021

    Harnessing Spatially-Resolved Gene Expression to Characterize the Transcriptional Landscape of Psoriatic Skin

    Rochelle Castillo1, Ikjot Sidhu1, Di Yan1, Piotr Konieczny1, Rebecca Haberman1, Brandon Hsieh1, Andrea Neimann1, Shruti Naik1 and Jose Scher2, 1NYU Langone Health, New York, NY, 2New York University School of Medicine, New York, NY

    Background/Purpose: The skin is recognized as a window into the immunopathogenic mechanisms in the psoriatic arthritis (PsA) joint. This is evidenced by the fact that…
  • Abstract Number: 005 • 2020 Pediatric Rheumatology Symposium

    Single Cell Sequencing of the Skin to Define Cell Populations of Interest in Localized Scleroderma (LS)

    Emily Mirizio 1, Wei Chen 2, Tao Sun 2, Tracy Tabib 3, Kaila Schollaert-Fitch 1, Robert Lafyatis 4, Heidi Jacobe 5 and Kathryn Torok1, 1Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, 2Research Computing Core at Children's Hospital of Pittsburgh, Pittsburgh, 3Univ of Pittsburgh Med Ctr, Pittsburgh, 4Univ of Pittsburgh Med Ctr, Pittsburgh, Pittsburgh, 5University of Texas Southwestern Medical Ctr, Dallas

    Background/Purpose: Scleroderma is an autoimmune disorder involving inflammatory driven fibrosis, which encompasses systemic sclerosis (SSc) and localized scleroderma (LS).  LS and SSc share histological characteristics,…
  • Abstract Number: 776 • 2019 ACR/ARP Annual Meeting

    Genetic Signatures Support Inflammation Driven Fibrosis in Localized Scleroderma

    Christina Schutt1, Emily Mirizio 2, Claudia Salgado 3, Miguel Reyes-Mugica 3, Kaila L. Schollaert 2 and Kathryn Torok 3, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, 3UPMC Children's Hospital of Pittsburgh, Pittsburgh

    Background/Purpose: Localized scleroderma (LS) is a progressive autoimmune disease of the skin and underlying tissue that is characterized by an initial inflammatory infiltration which is…
  • Abstract Number: 1931 • 2018 ACR/ARHP Annual Meeting

    Abundance of Plasma Microbial Small RNAs Are Predictive of Improvement in Disease Activity after DMARD Initiation for Rheumatoid Arthritis

    Michelle J. Ormseth1, Quanhu Sheng1, Shilin Zhao1, Joseph F. Solus1, Qiong Wu1, Ryan Allen1, Yan Guo1, Fei Ye1, Marisol Ramirez1, Kasey Vickers1, S. Louis Bridges Jr.2, Jeffrey R. Curtis3 and C Michael Stein1, 1Vanderbilt University Medical Center, Nashville, TN, 2Clinical Immunology & Rheum, Univ of Alabama, Birmingham, AL, 3University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Small RNAs (sRNAs) are important regulators of biological processes and are potential biomarkers of disease and drug response. We previously found that microbial sRNAs…
  • Abstract Number: 1967 • 2018 ACR/ARHP Annual Meeting

    Detection of Association of Long Noncoding RNA ATP6V0E2-AS1 Single Nucleotide Polymorphism with Susceptibility to Myeloperoxidase-ANCA Associated Vasculitis Based on Transcriptome Analysis

    Yuka Iwahashi1,2, Aya Kawasaki1,2, Takayo Tsuchiura3, Ken-ei Sada4, Fumio Hirano5,6, Daisuke Tsukui7, Shigeto Kobayashi8, Hidehiro Yamada9, Hiroshi Furukawa1,2,10, Kenji Nagasaka11, Takahiko Sugihara12, Nao Nishida3, Kunihiro Yamagata13, Takayuki Sumida14, Shigeto Tohma10,15, Shoichi Ozaki9, Hiroshi Hashimoto16, Hirofumi Makino17, Yoshihiro Arimura18, Hajime Kono19, Masayoshi Harigai20 and Naoyuki Tsuchiya1,2, 1University of Tsukuba, Graduate School of Comprehensive Human Sciences, Masters' Program in Medical Sciences, Tsukuba, Japan, 2University of Tsukuba, Faculty of Medicine, Molecular and Genetic Epidemiology Laboratory, Tsukuba, Japan, 3Genome Medical Science Project, National Center for Global Health and Medicine, Research Center for Hepatitis and Immunology, Ichikawa, Japan, 4Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 5Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Department of Rheumatology, Tokyo, Japan, 6Tokyo Medical and Dental UniversityGraduate School of Medical and Dental Sciences, Department of Lifetime Clinical Immunology, Tokyo, Japan, 7Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 8Department of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan, 9St. Marianna University, School of Medicine, Department of Internal Medicine, Kawasaki, Japan, 10National Hospital Organization Sagamihara l Hospital, Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan, 11Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan, 12Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 13University of Tsukuba, Faculty of Medicine, Department of Nephrology, Tsukuba, Japan, 14Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 15National Hospital Organization Tokyo National Hospital, Kiyose, Japan, 16Juntendo University School of Medicine, Tokyo, Japan, 17Okayama University Hospital, Okayama, Japan, 18Kyorin University School of Medicine, First Department of Internal Medicine, Tokyo, Japan, 19Teikyo University School of Medicine, Department of Internal Medicine, Tokyo, Japan, 20Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan

    Background/Purpose: Because of the low prevalence, only three genome-wide association studies, all from the Caucasian populations, have been reported on ANCA-associated vasculitis (AAV) thus far;…
  • Abstract Number: 2018 • 2018 ACR/ARHP Annual Meeting

    Microenvironment Driven Re-Shaping of Pathogenic T Effector and Regulatory Subset in Active Juvenile Idiopathic Arthritic Patients

    Jing Yao Leong1, Pavanish Kumar1, Phyllis Chen2, Joo Guan Yeo2,3, Camillus Chua2, Sharifah Nur Hazirah2, Suzan Saidin1, Thaschawee Arkachaisri2,3, Alessandro Consolaro4, Marco Gattorno5, Alberto Martini6 and Salvatore Albani2, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 3KK Women's and Children's Hospital, Singapore, Singapore, 4Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genova, Italy, 5Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genoa, Italy, 6Pediatric Rheumatology International Trial Organization (PRINTO) Coordinating Centre, Genoa, Italy

    Background/Purpose: We have previously identified two CD4 pathogenic circulatory subsets in both T effector (CPLs) and T regulatory (iaTreg) compartments that are both HLA-DR+, antigen…
  • Abstract Number: 2055 • 2018 ACR/ARHP Annual Meeting

    Laser Capture Microdissection to Interrogate B Cells in RA Synovial Tissue

    Javier Rangel-Moreno1, Nida Meednu2, Andrew McDavid3, Linda Callahan4, V. Kaye Thomas4, Jennifer Albrecht2, Edward F. DiCarlo5, Dana Orange6, Susan M. Goodman6, Laura T. Donlin7 and Jennifer Anolik2, 1Medicine- Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 3Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, 4University of Rochester Medical Center, Rochester, NY, 5Laboratory Medicine, Hospital for Special Surgery, New York, NY, 6Hospital for Special Surgery, New York, NY, 7Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Rheumatoid arthritis is an autoimmune disease characterized by immune cell infiltration in synovial tissue and progressive bone damage. B cells are abundant in the…
  • Abstract Number: 2101 • 2018 ACR/ARHP Annual Meeting

    UV-Induced Skin Inflammation Is Exacerbated in Lupus-Prone Ro60 Knockout Female Mice with Interferon Priming

    Masaoki Kawasumi1, Daiki Rokunohe1, Xizhang Sun2, Lena Tanaka2, Sladjana Skopelja-Gardner3, Edward Chiou2, Anne Davidson4, Sandra L. Wolin5 and Keith B. Elkon2, 1Medicine/Dermatology, University of Washington, Seattle, WA, 2Medicine/Rheumatology, University of Washington, Seattle, WA, 3University of Washington, Seattle, WA, 4Feinstein Institute for Medical Research, Manhasset, NY, 5National Cancer Institute, Frederick, MD

    Background/Purpose: Photosensitivity is a major symptom of lupus, and excessive sunlight can cause skin rashes and flares of disease activity in systemic lupus erythematosus (SLE).…
  • Abstract Number: 2517 • 2018 ACR/ARHP Annual Meeting

    The JAK1-Selective Inhibitor Filgotinib Reverses the Disease-Associated Transcriptional Profile Found in the Blood of Patients with Active Rheumatoid Arthritis

    Peter C. Taylor1, Bryan Downie2, Luting Zhuo2, Yevgeniy Gindin2, Jacqueline Tarrant3, Jinfeng Liu2, René Galien4 and Amer M Mirza5, 1University of Oxford Botnar Research Centre, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, 2Bioinformatics, Gilead Sciences Inc., Foster City, CA, 3Gilead Sciences Inc., Foster City, CA, 4Galapagos SASU, Romainville, France, 5Biomarker Sciences, Gilead Sciences Inc., Foster City, CA

    Background/Purpose: Filgotinib (FIL), an oral JAK1- selective inhibitor, has shown good safety and efficacy in active rheumatoid arthritis (RA) patients with inadequate response to MTX…
  • Abstract Number: 2933 • 2018 ACR/ARHP Annual Meeting

    Non-Invasive Tape Sampling Reveals RNA Gene Clusters in Cutaneous Lupus Erythematosus That Discriminate Affected from Unaffected and Healthy Volunteer Skin

    Joseph F. Merola1, Wenting Wang2, Carrie Wager3, Stefan Hamann2, Xueli Zhang3, Alice Thai2, Chris Roberts2, Christina Lam4, Cristina Musselli2, Galina Marsh2, Dania Rabah2, Catherine Barbey5, Nathalie Franchimont2 and Taylor L. Reynolds2, 1Clinical Unit for Research Innovation & Trials, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Biogen, Cambridge, MA, 3Formerly of Biogen, Cambridge, MA, 4Boston University Medical School, Boston, MA, 5Biogen, Zug, Switzerland

    Background/Purpose: Punch biopsy, the standard diagnostic and monitoring procedure for patients with cutaneous lupus erythematosus (CLE), impedes patient recruitment and follow up due to risk…
  • Abstract Number: 2950 • 2018 ACR/ARHP Annual Meeting

    10X Genomics-Based Single-Cell RNA-Seq Analysis Identifies a Transcriptional Landscape of Inflammation and Fibrosis in Lupus Nephritis​

    Hemant Suryawanshi1, Evan Der2, Pavel Morozov1, Robert M. Clancy3, Beatrice Goilav4, H. Michael Belmont3, Peter M. Izmirly5, Nicole Bornkamp6, Nicole Jordan7, Ming Wu3, Judith A. James8, Joel M. Guthridge9, Soumya Raychaudhuri10, Jill P. Buyon3, Chaim Putterman2 and Thomas Tuschl1, 1Howard Hughes Medical Institute and The Rockefeller University, New York, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3NYU School of Medicine, New York, NY, 4Division of Nephrology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, 5Rheumatology, NYU School of Medicine, New York, NY, 6Medicine, NYU School of Medicine, New York, NY, 7Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 8Oklahoma Medical Research Foundation, Oklahoma City, OK, 9Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 10Harvard Medical School, Boston, MA

    Background/Purpose: Renal histology remains a primary tool for classification and treatment decisions in lupus nephritis (LN). Single-cell RNA-seq (scRNA-seq) analysis may provide mechanistic insights into…
  • Abstract Number: 134 • 2018 ACR/ARHP Annual Meeting

    Exploration of T-Cell Signatures Following TCR Stimulation Using Single Cell RNA-Seq to Inform Treatment Response Studies in Rheumatoid Arthritis

    Paul Martin1, James Ding1, Ben Mulhearn1, Sebastien Viatte1 and Stephen Eyre1,2, 1Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom

    Background/Purpose: For rheumatoid arthritis (RA), as with many other rheumatic diseases, the importance of determining which therapy will work best, early in disease, to prevent…
  • Abstract Number: 924 • 2018 ACR/ARHP Annual Meeting

    10X Genomics-Based Single-Cell RNA-Seq and Low Input RNA-Seq Identify a Transcriptional Landscape Supporting Interferon in the Pathogenesis of Autoimmune-Associated Congenital Heart Block

    Hemant Suryawanshi1, Jill P. Buyon2, Miao Chang2, Thomas Tuschl1 and Robert M. Clancy2, 1Howard Hughes Medical Institute and The Rockefeller University, New York, NY, 2NYU School of Medicine, New York, NY

    Background/Purpose: Towards understanding the molecular mechanisms that link maternal anti-Ro antibodies to the development of conduction system disease in a second trimester fetus, single cell…
  • Abstract Number: 1119 • 2018 ACR/ARHP Annual Meeting

    Genetic Signatures from RNA Sequencing of Pediatric Localized Scleroderma (LS) Skin

    Emily Mirizio1, Roosha Mandal2, Qi Yan3, William Horne4, Kaila Schollaert-Fitch3 and Kathryn S. Torok5, 1Peds Rheum, University of Pittsburgh Med Ctr, Pittsburgh, PA, 2Carnegie Mellon University, Pittsburgh, PA, 3University of Pittsburgh Med Ctr, Pittsburgh, PA, 4Health Sciences Sequencing Core at Children's Hospital of Pittsburgh, Pittsburgh, PA, 5Pediatric Rheumatology, University of Pittsburgh Med Ctr, Pittsburgh, PA

    Background/Purpose: Localized scleroderma (LS) is a progressive disease of the skin and underlying tissue that causes significant functional disability and disfigurement, especially in developing children.…
  • Abstract Number: 1474 • 2018 ACR/ARHP Annual Meeting

    Circulating Transfer RNA-Derived Small RNAs Are Altered in Patients with Rheumatoid Arthritis

    Qiong Wu, Quanhu Sheng, Joseph F. Solus, Kasey Vickers, Ryan Allen, Shilin Zhao, Yan Guo, Fei Ye, C Michael Stein and Michelle J. Ormseth, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Small RNAs (sRNAs) are important gene regulators and markers of disease. Transfer RNA (tRNA)-derived sRNAs (tDRs), including tRNA fragments (tRFs) and halves (tRHs), are…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology